Rossari Biotech Limited has significantly expanded its manufacturing operations through two major capacity additions at its Dahej facility, as announced in a recent regulatory filing.

Expansion at Rossari Biotech's Dahej Facility

The company has successfully commissioned an expansion of its Dahej facility, adding 20,000 MTPA (Metric Tonnes Per Annum) to its production capacity. This addition brings Rossari Biotech's total installed capacity to 152,500 MTPA, marking a substantial increase in its manufacturing capabilities.

Unitop Chemicals Enhances Ethoxylation Capacity

In a parallel development, Unitop Chemicals Private Limited, a material subsidiary of Rossari Biotech, has commenced operations of a new 15,000 MTPA ethoxylation capacity at its Dahej facility. This expansion is part of a larger 30,000 MTPA capacity addition project. With this new addition, Unitop Chemicals' total ethoxylation capacity has reached 51,000 MTPA.

Future Expansion Plans

The company's disclosure also revealed plans for further growth. The second phase of Unitop Chemicals' expansion project is expected to be completed by the third quarter of the fiscal year 2026 (Q3 FY26). This phase will add the remaining 15,000 MTPA to complete the planned 30,000 MTPA expansion.

Strategic Implications

These capacity expansions represent significant steps for Rossari Biotech and its subsidiary:

1. Increased Production Capability: The additional capacity at both facilities positions the company to meet growing demand and potentially capture larger market share.

2. Technological Advancement: The focus on ethoxylation capacity at Unitop Chemicals suggests a strategic emphasis on this chemical process, which is crucial in various industries including personal care, home care, and industrial applications.

3. Phased Approach: The staged implementation of capacity additions, particularly at Unitop Chemicals, indicates a measured and strategic approach to growth.

Rossari Biotech's expansion efforts demonstrate the company's commitment to strengthening its manufacturing footprint and enhancing its position in the specialty chemicals sector. As these new capacities come online, stakeholders will likely be watching closely to see how they translate into business performance and market opportunities for the company.

Rossari Biotech Limited's material subsidiary, Unitop Chemicals Private Limited, has made a strategic move to support its future growth plans. The company has approved the acquisition of leasehold land rights in the Gujarat Industrial Development Corporation (GIDC) industrial estate in Dahej, Gujarat.

Transaction Details

The transaction involves the purchase of rights to approximately 12,600 square meters of leasehold land from Micro Resins Private Limited. The deal is valued at up to Rs 9.00 crores, excluding transfer charges and applicable duties. This acquisition aligns with Unitop Chemicals' long-term growth strategy, aiming to support future capacity expansion and create operational synergies with its existing facility.

Strategic Implications

The newly acquired land is adjacent to Unitop Chemicals' current operations in Dahej, Gujarat. This strategic location is expected to facilitate seamless integration with the company's existing infrastructure and potentially lead to improved operational efficiency.

Regulatory Compliance

In compliance with regulatory requirements, Rossari Biotech Limited has made the necessary disclosures under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed the stock exchanges about this material development involving its subsidiary.

Transaction Approval and Completion

The Board of Directors of Unitop Chemicals Private Limited approved this land acquisition in their meeting held on August 18, 2025. However, it's important to note that the completion of the transaction is subject to obtaining necessary approvals, consents, and permissions from the concerned authorities.

Arm's Length Transaction

Rossari Biotech has clarified that the parties involved in this transaction - Unitop Chemicals Private Limited and Micro Resins Private Limited - are not related to the promoter group. Furthermore, the company has confirmed that this deal does not fall under the category of related party transactions, ensuring transparency in the acquisition process.

This strategic land acquisition by Unitop Chemicals Private Limited demonstrates Rossari Biotech's commitment to expanding its operational capabilities and fostering long-term growth in the chemical sector.